CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $14.7M invested in Celyad Oncology SA American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$13.7M +$530K +25,980 +4%
Millennium Management
2
Millennium Management
New York
$554K -$1.29M -63,419 -70%
Morgan Stanley
3
Morgan Stanley
New York
$204K +$47K +2,298 +30%
Wells Fargo
4
Wells Fargo
California
$155K +$28.3K +1,390 +22%
UBS Group
5
UBS Group
Switzerland
$17K -$8.93K -453 -34%
Zurich Cantonal Bank
6
Zurich Cantonal Bank
Switzerland
$2K
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$2K
TRCT
8
Tower Research Capital (TRC)
New York
$1K -$1.68K -67 -63%